Literature DB >> 3265130

In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae.

J L Burns1, K Wong, A L Smith.   

Abstract

One hundred seventy-five clinical isolates of Haemophilus influenzae (including 74 beta-lactamase-producing strains) were examined for susceptibility to ampicillin, cefonicid, cefamandole, cefuroxime and cefotaxime. Cefonicid and cefamandole exhibited similar activity against ampicillin-susceptible strains (MIC90 = 0.2 mg/l for both antibiotics); cefuroxime was slightly less active (MIC90 = 0.01 mg/l). However, cefonicid, cefuroxime and cefotaxime were all more active against beta-lactamase-producing H. influenzae than cefamandole (MIC90 = 1.0 mg/l for cefonicid, MIC90 = 2.0 mg/l for cefuroxime, MIC90 = 0.01 mg/l for cefotaxime, MIC90 = 5.0 mg/l for cefamandole). One hundred twenty-five of the 175 isolates were also tested for susceptibility to cefonicid and cefamandole by disc diffusion technique and a plot of zone diameter vs. MIC was analyzed for the beta-lactamase-producing strains.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265130     DOI: 10.1007/bf01645075

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  19 in total

1.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics.

Authors:  E STEERS; E L FOLTZ; B S GRAVES
Journal:  Antibiot Chemother (Northfield)       Date:  1959-05

2.  Comparative activities of selected beta-lactam antibiotics against Haemophilus influenzae.

Authors:  J H Jorgensen; G A Alexander
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

3.  Treating community-acquired lower respiratory infection.

Authors:  B R Meyers
Journal:  Am Fam Physician       Date:  1983-09       Impact factor: 3.292

4.  Susceptibility of Haemophilus influenzae to chloramphenicol and eight beta-lactam antibiotics.

Authors:  M C Thirumoorthi; D M Kobos; A S Dajani
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

5.  Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin.

Authors:  M G Bergeron; S Claveau; P Simard
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

6.  Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics.

Authors:  V P Syriopoulou; D W Scheifele; C M Sack; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

7.  Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.

Authors:  H J Dabernat; C Delmas
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

8.  In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins.

Authors:  S Shelton; J D Nelson; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

9.  [Study of ampicillin sensitivity of 148 strains of Haemophilus influenzae isolated in 2 general hospitals].

Authors:  L D Berardi-Grassias; A Boisivon; M L Bigel
Journal:  Pathol Biol (Paris)       Date:  1987-05

10.  In vitro activity of ceftazidime (GR 20263) and other beta-lactam antibiotics against Haemophilus influenzae.

Authors:  P Piot; E Van Dyck; J Colaert
Journal:  Infection       Date:  1983       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.